The present study investigates the therapeutic potential of kiwifruit extract, specifically its cysteine protease inhibitor with crude protein kiwi extract (CPKE), in mitigating symptoms and inflammation associated with DNCB-induced AD. The gene discussed is CTSB; the disease is Alzheimer disease.